The small molecule drug discovery market was valued at US$ 24,976.14 million in 2019 and is projected to reach US$ 50,823.06 Mn by 2027; it is expected to grow at a CAGR of 9.5% from 2020 to 2027.
Small molecules drugs are used in targeted drug delivery in which small molecules pass through the cell membrane and acts on the specific cellular organelle or protein. The small molecules drugs are able to enter cells easily because of its low molecular weight. These molecules are better than monoclonal antibodies and other large molecule drugs due to their size, easy convertibility to oral form and, cost-effectiveness. The small molecule drug discovery market is expected to witness huge growth due to increasing approval of small molecule drugs, growing demand for R&D from contract organizations, and rising adoption of small molecules in chronic disease treatments. However, high drug development cost is expected to restrain the growth of the market during the forecast period.
Lucrative Regions for Small Molecule Drug Discovery Market
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Market Insights
Rising Adoption of Small Molecules in Chronic Disease Treatments
As per the Centres for Disease Control (CDC), 6 in 10 adults suffer from a chronic condition, such as heart disease, diabetes, cancer, kidney disease, lung disease, or stroke in the US, costing US$ 3.5 trillion to the economy in the US annually for the treatment of these chronic diseases. Chronic diseases are the most significant cause of deaths worldwide, and the number is growing every year. For instance, as per the CDC, more than 1.6 million people are diagnosed with cancer every year in the US.
Small-molecule medicines are expected to provide effective treatment options for chronic diseases owing to their size and ability to cross cell barriers. They can also be designed to cross the blood-brain barrier to target neurological illnesses. Small molecules are expected to play a critical role in reducing the burden of chronic disease. In the coming years, small molecules are expected to help with the formulation of more efficient and effective treatments for chronic conditions.
Therapeutic Area -Based Insights
Based on therapeutic area, the small molecule drug discovery market is segmented into oncology, central nervous system, cardiovascular, respiratory, orthopedics, immunology, rare diseases, and other therapeutic areas. The oncology segment held a largest share of the market in 2019 owing to the increasing small molecule drug approvals and growing pipeline for the cancer therapeutics. Moreover, increasing investment in oncology is further driving the growth of the segment. For instance, In December 2019, Zentalis Pharmaceuticals, a clinical-stage biopharmaceutical company focused on developing clinically differentiated, novel small molecule therapeutics that target fundamental pathways in cancer, completed US$ 85 million Series C financing. However, the rare diseases segment is expected to register a higher CAGR in the market during the forecast period.
Global Small Molecule Drug Discovery Market, by Therapeutic Area – 2019 & 2027
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Process/Phase -Based Insights
Based on process/phase, the small molecule drug discovery market is segmented into target discovery, target validation, lead generation and refinement, and preclinical development. The lead generation and refinement segment held the largest share of the global small molecule drug discovery market in 2019, owing to increasing investment in drug discovery and rising demand of cost-effective therapeutics. Moreover, the discovery of the target involves identification of disease modifying targets, which acts as one of the essential steps in drug discovery pipeline. However, the target discovery is anticipated to register the highest CAGR during the forecast period.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Small Molecule Drug Discovery Market: Strategic Insights
Market Size Value in US$ 24,976.14 Million in 2019 Market Size Value by US$ 50,823.06 Million by 2027 Growth rate CAGR of 9.5% from 2020-2027 Forecast Period 2020-2027 Base Year 2020
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Small Molecule Drug Discovery Market: Strategic Insights
| Market Size Value in | US$ 24,976.14 Million in 2019 |
| Market Size Value by | US$ 50,823.06 Million by 2027 |
| Growth rate | CAGR of 9.5% from 2020-2027 |
| Forecast Period | 2020-2027 |
| Base Year | 2020 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Collaborations and expansion strategy are commonly adopted by companies to expand their footprint worldwide and meet the growing demand in order to expand its product portfolio.
The market players operating in the small molecule drug discovery market adopted the strategy of product innovation to cater to changing customer demand across the world, which also permits the players to maintain their brand name globally.
Small Molecule Drug Discovery Market – By Therapeutic Area
- Oncology
- Central Nervous System
- Cardiovascular
- Respiratory
- Orthopedics
- Immunology
- Rare Diseases
- Other Therapeutic Areas
Small Molecule Drug Discovery Market – By Process/Phase
- Target Discovery
- Target Validation
- Lead Generation and Refinement
- Preclinical Development
Small Molecule Drug Discovery Market– By Geography
North America
- US
- Canada
- Mexico
Europe
- France
- Germany
- Italy
- UK
- Spain
- Rest of Europe
Asia Pacific(APAC)
- China
- India
- South Korea
- Japan
- Australia
- Rest of APAC
Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Rest of MEA
South America (SAM)
- Brazil
- Argentina
- Rest of SAM
Company Profiles
- Johnson and Johnson Services, Inc.
- Teva Pharmaceutical Industries Ltd
- Boehringer Ingelheim International GmbH
- Allergan Plc.
- Pfizer Inc.
- Bristol-Myers Squibb Company
- MERCK KGaA
- GlaxoSmithKline plc.
- AstraZeneca
- Gilead Sciences, Inc.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Therapeutic Area ; Process/Phase ; and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
Small molecules drugs are used in targeted drug delivery in which small molecules pass through the cell membrane and acts on the specific cellular organelle or protein. The small molecules drugs are able to enter cells easily because of its low molecular weight. These molecules are better than monoclonal antibodies and other large molecule drugs due to their size, easy convertibility to oral form and cost affectivity. The discovery of novel small molecule entities that are capable of specific interactions represents a significant challenge in the early stages of drug discovery. When the biological target is well defined and understood, the rational design of small molecule ligands is possible. In the recent years, the small molecules have witnessed significant attention over biologics, as there is an increasing demand for these drugs.
The factors that are driving growth of the market are increasing approval of small molecule drugs, growing demand for R&D from contract organizations, and rising adoption of small molecules in chronic disease treatments propel the growth of the market.
The small molecule drug discovery market majorly consists of the players such as Pfizer Inc., Bristol-Myers Squibb Company, Merck KGaA, GlaxoSmithKline Plc, AstraZeneca, Johnson & Johnson Services, Inc., TEVA PHARMACEUTICAL INDUSTRIES LTD, Boehringer Ingelheim International GmbH, and Allergan Plc.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Small Molecule Drug Discovery Market – By Therapeutic Area
1.3.2 Global Small Molecule Drug Discovery Market – By Process/Phase
1.3.3 Global Small Molecule Drug Discovery Market – By Geography
2. Small Molecule Drug Discovery Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Small Molecule Drug Discovery – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Europe– PEST Analysis
4.2.2 Asia Pacific– PEST Analysis
4.2.3 Middle East & Africa
4.2.4 South and Central America
4.3 Expert Opinion
5. Global Small Molecule Drug Discovery Market – Industry Dynamics
5.1 Market Drivers
5.1.1 Increasing Approval of Small Molecule Drugs
5.1.2 Growing Demand for R&D from Contract Organizations
5.1.3 Rising Adoption of Small Molecules in Chronic Disease Treatments
5.2 Market Restraints
5.2.1 High Drug Development Cost
5.3 Market Opportunities
5.3.1 Increasing Small Molecule-Based Pipeline
5.4 Future Trends
5.4.1 Growing Adoption of Artificial Intelligence in Drug Discovery
5.5 Impact analysis
6. Small Molecule Drug Discovery Market – Global Analysis
6.1 Global Small Molecule Drug Discovery Market Revenue Forecast And Analysis
6.2 Global Small Molecule Drug Discovery Market, By Geography - Forecast And Analysis
6.3 Market Positioning of Key Players
7. Small Molecule Drug Discovery Market – By Therapeutic Area
7.1 Overview
7.2 Small Molecule Drug Discovery Market Share, by Therapeutic Area, 2019 and 2027 (%)
7.3 Oncology
7.3.1 Overview
7.3.2 Oncology: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)
7.4 Central Nervous System
7.4.1 Overview
7.4.2 Central Nervous System: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)
7.5 Cardiovascular
7.5.1 Overview
7.5.2 Cardiovascular: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)
7.6 Respiratory
7.6.1 Overview
7.6.2 Respiratory: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)
7.7 Orthopedics
7.7.1 Overview
7.7.2 Orthopedics: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)
7.8 Immunology
7.8.1 Overview
7.8.2 Immunology: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)
7.9 Rare Diseases
7.9.1 Overview
7.9.2 Rare Diseases: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)
7.10 Other Therapeutic Areas
7.10.1 Overview
7.10.2 Other Therapeutic Areas: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)
8. Small Molecule Drug Discovery Market – By Process/Phase
8.1 Overview
8.2 Small Molecule Drug Discovery Market, by Process/Phase, 2019 and 2027 (%)
8.3 Target Discovery
8.3.1 Overview
8.3.2 Target Discovery: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (US$ Million)
8.4 Target Validation
8.4.1 Overview
8.4.2 Target Validation: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (US$ Million)
8.5 Lead Generation and Refinement
8.5.1 Overview
8.5.2 Lead Generation and Refinement: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (US$ Million)
8.6 Preclinical Development
8.6.1 Overview
8.6.2 Preclinical Development: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (US$ Million)
9. Small Molecule Drug Discovery Market – Geographic Analysis
9.1 North America: Small Molecule Drug Discovery Market
9.1.1 Overview
9.1.2 North America: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (USD Million)
9.1.3 North America Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027 (USD Million)
9.1.4 North America Small Molecule Drug Discovery Market, by Process/ Phase – Revenue and Forecast to 2027 (USD Million)
9.1.5 North America: Small Molecule Drug Discovery Market, by Country, 2019 & 2027 (%)
9.1.5.1 US: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (USD Million)
9.1.5.1.1 US: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (USD Million)
9.1.5.1.2 US Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027 (USD Million)
9.1.5.1.3 US Skin aesthetic devices market, by Process/ Phase – Revenue and Forecast to 2027 (USD Million)
9.1.5.2 Canada: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (USD Million)
9.1.5.2.1 Canada: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (USD Million)
9.1.5.2.2 Canada Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027 (USD Million)
9.1.5.2.3 Canada Small Molecule Drug Discovery Market, by Process/ Phase – Revenue and Forecast to 2027 (USD Million)
9.1.5.3 Mexico: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (USD Million)
9.1.5.3.1 Mexico: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (USD Million)
9.1.5.3.2 Mexico Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027 (USD Million)
9.1.5.3.3 Mexico Small Molecule Drug Discovery Market, by Process/ Phase – Revenue and Forecast to 2027 (USD Million)
9.2 Europe: Small Molecule Drug Discovery Market
9.2.1 Overview
9.2.2 Europe: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (USD Millions)
9.2.3 Europe: Small Molecule Drug Discovery Market, by Therapeutic Area, 2018–2027 (USD Millions)
9.2.4 Europe: Small Molecule Drug Discovery Market, by Process/ Phase, 2018-2027 (USD Millions)
9.2.5 Europe: Small Molecule Drug Discovery Market, by Country, 2019 & 2027 (%)
9.2.5.1 Germany: Small Molecule Drug Discovery Market
9.2.5.1.1 Germany: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (USD Millions)
9.2.5.1.2 Germany: Small Molecule Drug Discovery Market, by Therapeutic Area, 2018-2027 (USD Millions)
9.2.5.1.3 Germany: Small Molecule Drug Discovery Market, by Process/ Phase, 2018-2027 (USD Millions)
9.2.5.2 United Kingdom: Small Molecule Drug Discovery Market
9.2.5.2.1 United Kingdom: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (USD Millions)
9.2.5.2.2 United Kingdom: Small Molecule Drug Discovery Market, by Therapeutic Area, 2018-2027 (USD Millions)
9.2.5.2.3 United Kingdom: Small Molecule Drug Discovery Market, by Process/ Phase, 2018-2027 (USD Millions)
9.2.5.3 France: Small Molecule Drug Discovery Market
9.2.5.3.1 France: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (USD Millions)
9.2.5.3.2 France: Small Molecule Drug Discovery Market, by Therapeutic Area, 2018-2027 (USD Millions)
9.2.5.3.3 France: Small Molecule Drug Discovery Market, by Process/ Phase, 2018-2027 (USD Millions)
9.2.5.4 Italy: Small Molecule Drug Discovery Market
9.2.5.4.1 Italy: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (USD Millions)
9.2.5.4.2 Italy: Small Molecule Drug Discovery Market, by Therapeutic Area, 2018-2027 (USD Millions)
9.2.5.4.3 Italy: Small Molecule Drug Discovery Market, by Process/ Phase, 2018-2027 (USD Millions)
9.2.5.5 Spain: Small Molecule Drug Discovery Market
9.2.5.5.1 Spain: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (USD Millions)
9.2.5.5.2 Spain: Small Molecule Drug Discovery Market, by Therapeutic Area, 2018-2027 (USD Millions)
9.2.5.5.3 Spain: Small Molecule Drug Discovery Market, by Process/ Phase, 2018-2027 (USD Millions)
9.3 Asia Pacific: Small Molecule Drug Discovery Market
9.3.1 Overview
9.3.2 Asia Pacific: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (USD Millions)
9.3.3 Asia Pacific: Small Molecule Drug Discovery Market, by Therapeutic Area, 2018-2027 (USD Millions)
9.3.4 Asia Pacific: Small Molecule Drug Discovery Market, by Process/ Phase, 2018-2027 (USD Millions)
9.3.5 Asia Pacific: Small Molecule Drug Discovery Market, by Country, 2019 & 2027 (%)
9.3.5.1 China: Small Molecule Drug Discovery Market
9.3.5.1.1 China: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (USD Millions)
9.3.5.1.2 China: Small Molecule Drug Discovery Market, by Therapeutic Area, 2018-2027 (USD Millions)
9.3.5.1.3 China: Small Molecule Drug Discovery Market, by Process/ Phase, 2018-2027 (USD Millions)
9.3.5.2 Japan: Small Molecule Drug Discovery Market
9.3.5.2.1 Japan: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (USD Millions)
9.3.5.2.2 Japan: Small Molecule Drug Discovery Market, by Therapeutic Area, 2018-2027 (USD Millions)
9.3.5.2.3 Japan: Small Molecule Drug Discovery Market, by Process/ Phase, 2018-2027 (USD Millions)
9.3.5.3 India: Small Molecule Drug Discovery Market
9.3.5.3.1 India: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (USD Millions)
9.3.5.3.2 India: Small Molecule Drug Discovery Market, by Therapeutic Area, 2018-2027 (USD Millions)
9.3.5.3.3 India: Small Molecule Drug Discovery Market, by Process/ Phase, 2018-2027 (USD Millions)
9.3.5.4 South Korea: Small Molecule Drug Discovery Market
9.3.5.4.1 South Korea: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (USD Millions)
9.3.5.4.2 South Korea: Small Molecule Drug Discovery Market, by Therapeutic Area, 2018-2027 (USD Millions)
9.3.5.4.3 South Korea: Small Molecule Drug Discovery Market, by Process/ Phase, 2018-2027 (USD Millions)
9.3.5.5 Australia: Small Molecule Drug Discovery Market
9.3.5.5.1 Australia: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (USD Millions)
9.3.5.5.2 Australia: Small Molecule Drug Discovery Market, by Therapeutic Area, 2018-2027 (USD Millions)
9.3.5.5.3 Australia: Small Molecule Drug Discovery Market, by Process/ Phase, 2018-2027 (USD Millions)
9.4 Middle East and Africa: Small Molecule Drug Discovery Market
9.4.1 Overview
9.4.2 Middle East and Africa: Small Molecule Drug Discovery Market- Revenue and Forecast to 2027 (USD Million)
9.4.3 Middle East and Africa Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027 (USD Million)
9.4.4 Middle East and Africa Immunodiagnostics Market, by Process/Phase – Revenue and Forecast to 2027 (USD Million)
9.4.5 Middle East and Africa: Small Molecule Drug Discovery Market, by Country, 2019 & 2027 (%)
9.4.5.1 Saudi Arabia: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (USD Million)
9.4.5.1.1 Saudi Arabia: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (USD Million)
9.4.5.1.2 Saudi Arabia Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027 (USD Million)
9.4.5.1.3 Saudi Arabia Immunodiagnostics, by Process/Phase – Revenue and Forecast to 2027 (USD Million)
9.4.5.2 UAE: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (USD Million)
9.4.5.2.1 UAE: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (USD Million)
9.4.5.2.2 UAE Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027 (USD Million)
9.4.5.2.3 UAE Immunodiagnostics Market, by Process/Phase – Revenue and Forecast to 2027 (USD Million)
9.4.5.3 South Africa: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (USD Million)
9.4.5.3.1 South Africa: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (USD Million)
9.4.5.3.2 South Africa Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027 (USD Million)
9.4.5.3.3 South Africa Immunodiagnostics Market, by Process/Phase – Revenue and Forecast to 2027 (USD Million)
9.5 South and Central America: Small Molecule Drug Discovery Market
9.5.1 Overview
9.5.2 South and Central America: Small Molecule Drug Discovery Market - Revenue and Forecast to 2027 (USD Million)
9.5.3 South and Central America Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027 (USD Million)
9.5.4 South and Central America Small Molecule Drug Discovery Market, by Process/Phase – Revenue and Forecast to 2027 (USD Million)
9.5.5 South and Central America: Small Molecule Drug Discovery Market, by Country, 2019 & 2027 (%)
9.5.5.1 Brazil: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (USD Million)
9.5.5.1.1 Brazil: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (USD Million)
9.5.5.1.2 Brazil Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027 (USD Million)
9.5.5.1.3 Brazil Small Molecule Drug Discovery Market, by Process/Phase – Revenue and Forecast to 2027 (USD Million)
9.5.5.2 Argentina: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (USD Million)
9.5.5.2.1 Argentina: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (USD Million)
9.5.5.2.2 Argentina Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027 (USD Million)
9.5.5.2.3 Argentina Small Molecule Drug Discovery Market, by Process/Phase – Revenue and Forecast to 2027 (USD Million)
10. Impact of COVID-19 Pandemic on Global Small Molecule Drug Discovery Market
10.1 North America: Impact Assessment of COVID-19 Pandemic
10.2 Europe: Impact Assessment of COVID-19 Pandemic
10.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
10.4 Rest of the World: Impact Assessment of COVID-19 Pandemic
11. Small Molecule Drug Discovery Market –Industry Landscape
11.1 Overview
11.2 Growth Strategies Done by the Companies in the Market, (%)
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic Developments
11.4.1 Overview
12. Small Molecule Drug Discovery Market –Company Profiles
12.1 Pfizer Inc.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Bristol-Myers Squibb Company
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Merck KGaA
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 GlaxoSmithKline plc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 AstraZeneca
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Johnson & Johnson Services, Inc.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Gilead Sciences, Inc.
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Teva Pharmaceutical Industries Ltd
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Boehringer Ingelheim International GmbH
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Allergan Plc.
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027 (USD Million)
Table 2. North America Small Molecule Drug Discovery Market, by Process/ Phase – Revenue and Forecast to 2027 (USD Million)
Table 3. US Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027 (USD Million)
Table 4. US Skin aesthetic devices market, by Process/ Phase – Revenue and Forecast to 2027 (USD Million)
Table 5. Canada Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027 (USD Million)
Table 6. Canada Small Molecule Drug Discovery Market, by Process/ Phase – Revenue and Forecast to 2027 (USD Million)
Table 7. Mexico Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027 (USD Million)
Table 8. Mexico Small Molecule Drug Discovery Market, by Process/ Phase – Revenue and Forecast to 2027 (USD Million)
Table 9. Europe Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027 (USD Millions)
Table 10. Europe Small Molecule Drug Discovery Market, by Process/ Phase – Revenue and Forecast to 2027 (USD Millions)
Table 11. Germany Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027 ( USD Millions)
Table 12. Germany Small Molecule Drug Discovery Market, by Process/ Phase – Revenue and Forecast to 2027 (USD Millions)
Table 13. United Kingdom Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027 (USD Millions)
Table 14. United Kingdom Small Molecule Drug Discovery Market, by Process/ Phase – Revenue and Forecast to 2027 (USD Millions)
Table 15. France Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027 (USD Millions)
Table 16. France Small Molecule Drug Discovery Market, by Process/ Phase – Revenue and Forecast to 2027 (USD Millions)
Table 17. Italy Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027 (USD Millions)
Table 18. Italy Small Molecule Drug Discovery Market, by Process/ Phase – Revenue and Forecast to 2027 (USD Millions)
Table 19. Spain Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027 (USD Millions)
Table 20. Spain Small Molecule Drug Discovery Market, by Process/ Phase – Revenue and Forecast to 2027 (USD Millions)
Table 21. Asia Pacific Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027 (USD Millions)
Table 22. Asia Pacific Small Molecule Drug Discovery Market, by Process/ Phase – Revenue and Forecast to 2027 (USD Millions)
Table 23. China Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027 (USD Millions)
Table 24. China Small Molecule Drug Discovery Market, by Process/ Phase – Revenue and Forecast to 2027 (USD Millions)
Table 25. Japan Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027 (USD Millions)
Table 26. Japan Small Molecule Drug Discovery Market, by Process/ Phase – Revenue and Forecast to 2027 (USD Millions)
Table 27. India Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027 (USD Millions)
Table 28. India Small Molecule Drug Discovery Market, by Process/ Phase – Revenue and Forecast to 2027 (USD Millions)
Table 29. South Korea Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027 (USD Millions)
Table 30. South Korea Small Molecule Drug Discovery Market, by Process/ Phase – Revenue and Forecast to 2027 (USD Millions)
Table 31. Australia Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027 (USD Millions)
Table 32. Australia Small Molecule Drug Discovery Market, by Process/ Phase – Revenue and Forecast to 2027 (USD Millions)
Table 33. North America Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027 (USD Million)
Table 34. Middle East and Africa Immunodiagnostics Market, by Process/Phase – Revenue and Forecast to 2027 (USD Million)
Table 35. Saudi Arabia Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027 (USD Million)
Table 36. Saudi Arabia Immunodiagnostics Market, by Process/Phase – Revenue and Forecast to 2027 (USD Million)
Table 37. UAE Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027 (USD Million)
Table 38. UAE Immunodiagnostics Market, by Process/Phase – Revenue and Forecast to 2027 (USD Million)
Table 39. South Africa Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027 (USD Million)
Table 40. South Africa Small Molecule Drug Discovery Market, by Process/Phase – Revenue and Forecast to 2027 (USD Million)
Table 41. South and Central America Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027 (USD Million)
Table 42. South and Central America Small Molecule Drug Discovery Market, by Process/Phase – Revenue and Forecast to 2027 (USD Million)
Table 43. Brazil Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027 (USD Million)
Table 44. Brazil Small Molecule Drug Discovery Market, by Process/Phase – Revenue and Forecast to 2027 (USD Million)
Table 45. Argentina Small Molecule Drug Discovery Market, by Therapeutic Area – Revenue and Forecast to 2027 (USD Million)
Table 46. Argentina Small Molecule Drug Discovery Market, by Process/Phase – Revenue and Forecast to 2027 (USD Million)
Table 47. Organic Developments Done By Companies
Table 48. Inorganic Developments Done By Companies
Table 49. Glossary of Terms, Small Molecule Drug Discovery Market
LIST OF FIGURES
Figure 1. Small Molecule Drug Discovery Market Segmentation
Figure 2. Small Molecule Drug Discovery Segmentation, By Region
Figure 3. Global Small Molecule Drug Discovery Market Overview
Figure 4. The Oncology Segment Held Largest Share and Rare Diseases Segment Expected To Grow With Highest Growth Rate
Figure 5. Asia-Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Global Small Molecule Drug Discovery Market, By Geography (US$ Million)
Figure 7. Global Small Molecule Drug Discovery Market, Industry Landscape
Figure 8. Global Small Molecule Drug Discovery Market- Leading Country Markets (US$ Million)
Figure 9. North America PEST Analysis
Figure 10. Europe PEST Analysis
Figure 11. Asia Pacific PEST Analysis
Figure 12. Middle East & Africa PEST Analysis
Figure 13. South and Central America PEST Analysis
Figure 14. Small molecule drug discovery Market Impact Analysis of Driver and Restraints
Figure 15. Global Small Molecule Drug Discovery Market – Revenue Forecast And Analysis – 2019- 2027
Figure 16. Global Small Molecule Drug Discovery Market – By Geography Forecast and Analysis – 2019- 2027
Figure 17. Market Positioning of Key Players In Global Small Molecule Drug Discovery Market
Figure 18. Small Molecule Drug Discovery Market Share, by Therapeutic Area, 2019 and 2027 (%)
Figure 19. Oncology: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)
Figure 20. Central Nervous System: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)
Figure 21. Cardiovascular: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)
Figure 22. Respiratory: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)
Figure 23. Orthopedics: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)
Figure 24. Immunology: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)
Figure 25. Rare Diseases: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)
Figure 26. Other Therapeutic Areas: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (US$ million)
Figure 27. Small Molecule Drug Discovery Market, by Process/Phase, 2019 and 2027 (%)
Figure 28. Target Discovery: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 29. Target Validation: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 30. Lead Generation and Refinement: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 31. Preclinical Development: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (US$ Million)
Figure 32. North America: Small Molecule Drug Discovery Market, by Key Country – Revenue (2019) (USD Million)
Figure 33. North America Small Molecule Drug Discovery Market Revenue and Forecast to 2027 (USD Million)
Figure 34. North America: Small Molecule Drug Discovery Market, by Country, 2019 & 2027 (%)
Figure 35. US: Small Molecule Drug Discovery market – Revenue and Forecast to 2027 (USD Million)
Figure 36. Canada: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (USD Million)
Figure 37. Mexico: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (USD Million)
Figure 38. Europe: Small Molecule Drug Discovery Market, by Key Country – Revenue (2019) (USD Millions)
Figure 39. Europe Small Molecule Drug Discovery Market Revenue and Forecast to 2027 (USD Millions)
Figure 40. Europe: Small Molecule Drug Discovery Market, by Country, 2019 & 2027 (%)
Figure 41. Germany Small Molecule Drug Discovery Market Revenue and Forecast to 2027 (USD Millions)
Figure 42. United Kingdom Small Molecule Drug Discovery Market Revenue and Forecast to 2027 (USD Millions)
Figure 43. France Small Molecule Drug Discovery Market Revenue and Forecast to 2027 (USD Millions)
Figure 44. Italy Small Molecule Drug Discovery Market Revenue and Forecast to 2027 (USD Millions)
Figure 45. Spain Small Molecule Drug Discovery Market Revenue and Forecast to 2027 (USD Millions)
Figure 46. Asia Pacific: Small Molecule Drug Discovery Market, by Key Country – Revenue (2019) (USD Millions)
Figure 47. Asia Pacific Small Molecule Drug Discovery Market Revenue and Forecast to 2027 (USD Millions)
Figure 48. Asia Pacific: Small Molecule Drug Discovery Market, by Country, 2019 & 2027 (%)
Figure 49. China Small Molecule Drug Discovery Market Revenue and Forecast to 2027 (USD Millions)
Figure 50. Japan Small Molecule Drug Discovery Market Revenue and Forecast to 2027 (USD Millions)
Figure 51. India Small Molecule Drug Discovery Market Revenue and Forecast to 2027 (USD Millions)
Figure 52. South Korea Small Molecule Drug Discovery Market Revenue and Forecast to 2027 (USD Millions)
Figure 53. Australia Small Molecule Drug Discovery Market Revenue and Forecast to 2027 (USD Millions)
Figure 54. Middle East and Africa: Small Molecule Drug Discovery Market, by Key Country – Revenue (2019) (USD Million)
Figure 55. Middle East and Africa Small Molecule Drug Discovery Market Revenue and Forecast to 2027 (USD Million)
Figure 56. North America: Small Molecule Drug Discovery Market, by Country, 2019 & 2027 (%)
Figure 57. Saudi Arabia: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (USD Million)
Figure 58. UAE: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (USD Million)
Figure 59. South Africa: Small Molecule Drug Discovery Market– Revenue and Forecast to 2027 (USD Million)
Figure 60. South and Central America: Small Molecule Drug Discovery Market, by Key Country – Revenue (2019) (USD Million)
Figure 61. South and Central America Small Molecule Drug Discovery Market Revenue and Forecast to 2027 (USD Million)
Figure 62. South and Central America: Small Molecule Drug Discovery Market, by Country, 2019 & 2027 (%)
Figure 63. Brazil: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (USD Million)
Figure 64. Argentina: Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (USD Million)
Figure 65. Impact of COVID-19 Pandemic In North American Country Markets
Figure 66. Impact of COVID-19 Pandemic In European Country Markets
Figure 67. Impact of COVID-19 Pandemic In Asia Pacific Country Markets
Figure 68. Impact Of COVID-19 Pandemic In Rest of the World Market
Figure 69. Growth Strategies Done by the Companies in the Market, (%)
The List of Companies - Small Molecule Drug Discovery Market
- Johnson and Johnson Services, Inc.
- Teva Pharmaceutical Industries Ltd
- Boehringer Ingelheim International GmbH
- Allergan Plc.
- Pfizer Inc.
- Bristol-Myers Squibb Company
- MERCK KGaA
- GlaxoSmithKline plc.
- AstraZeneca
- Gilead Sciences, Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Small Molecule Drug Discovery Market
May 2020
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
May 2020
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
May 2020
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
May 2020
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
May 2020
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
May 2020
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
May 2020
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
May 2020
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)